Back to mobile site

Allergan (AGN), KYTHERA Biopharma (KYTH) Announce Early HSR Act Termination in Proposed Merger

July 27, 2015 4:46 PM EDT Send to a Friend
Allergan (NYSE: AGN) and KYTHERA Biopharmaceuticals, Inc. (Nasdaq: KYTH) announced that the U.S. Federal Trade Commission (FTC) has granted early ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login